BHC Bausch Health Companies Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 69
Relative Strength: Rel. Strength: 56
Relative Valuation: Rel. Valuation: 99
Relative Profitability: Rel. Profitability: 68

EPS in 2025 (TTM): $0.97

Last Report Period Date: Sep 30, 2025

According to the most recent financial data from September 2025, the EPS for the trailing twelve months is $0.97. Bausch Health Companies's EPS for 2024 amounted to -$0.13, marking an increase from -$1.62 in 2023. During the quarterly period ending on Sep 30, 2025, BHC's EPS stood at $0.48.

BHC earnings history

Historical annual and quarterly earnings per share (EPS) data for Bausch Health Companies
EPS (TTM)
$0.97
EPS Growth YoY (Quarterly)
308.7%
EPS (Quarterly)
$0.48
EPS Growth (Quarterly)
20%

Bausch Health Companies had an annual EPS of -$0.13, indicating an increase of 92% from -$1.62 in 2023. The quarterly per-share earnings for the period ending Sep 30, 2025, was $0.48, indicating a 308.7% increase from the same quarter last year. BHC's 12-month EPS stands at $0.97 as of September 2025. Bausch Health Companies's annual EPS in 2023 stood at -$1.62, a 161.3% decrease year-over-year.

BHC EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
308.7%
EPS growth YoY
92%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Bausch Health Companies has registered an increase in EPS of 308.7% during the last 12 months (YoY, quarterly).

BHC Earnings Waterfall

Breakdown of revenue, profit and net income for Bausch Health Companies

BHC Earnings vs Peers

What are the earnings of BHC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BHC Bausch Health Companies Inc 6.99 92% N/A N/A
OPK Opko Health Inc N/A 68% N/A N/A
ORGO Organogenesis Holdings Inc N/A -125% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.